Featured Research

from universities, journals, and other organizations

University of Florida Researchers Explore Gene Therapy To Treat Obesity

Date:
June 11, 1999
Source:
University Of Florida
Summary:
While testing in humans is years away, the research holds promise that a single injection may someday be a viable option for treating obesity, a widespread health problem that continues to defy most control efforts.

By Eric Benjamin Lowe

Related Articles


GAINESVILLE, Fla.---University of Florida scientists have successfully used gene therapy to control appetite and weight in obese animal models, they announced this week.

While testing in humans is years away, the research holds promise that a single injection may someday be a viable option for treating obesity, a widespread health problem that continues to defy most control efforts.

The researchers are scheduled to present their findings Thursday (6/10/99) at the annual meeting of the American Society of Gene Therapy in Washington, D.C.

"This would be the couch potato's dream: You can eat what you want but stay lean," said Sergei Zolotukhin, a research associate professor of molecular genetics and microbiology in UF's College of Medicine.

An estimated 54 percent of adults in the United States are overweight,according to the National Institutes of Health. Treating obesity and its related conditions, including high blood pressure, heart disease and diabetes, is estimated to cost more than $45 billion annually, according to an August 1996 Scientific American article.

"With the incidence of obesity on the rise in the United States, we need to develop therapies that will alleviate the symptoms associated with obesity," said Harveen Dhillon, a third-year College of Medicine graduate student in UF's interdisciplinary biomedical sciences program. Dhillon is the research team's lead presenter at this week's meeting.

The UF scientists injected mice and rats with genes that increased the production of two appetite-controlling compounds already existing in the body- leptin and ciliary neurotrophic factor, or CNTF.

Leptin is a naturally occurring protein produced by fat cells thatinhibits appetite and increases energy expenditure. It signals the brain, affecting the brain's secretion of appetite-regulating signals. Such signalsinclude neuropeptide Y, a chemical that UF researchers found stimulates appetite, said Satya Kalra, a professor of neuroscience in UF's College of Medicine. This process is thought to be faulty in most obese people so that even high levels of leptin fail to turn off the hunger signal.

"The concept is that if you can turn off the production of neuropeptide Y and other appetite-stimulating signals by increasing leptin levels, it is possible to control body weight," said Kalra, who also is affiliated with UF's Gene Therapy Center and UF's Brain Institute.

Researchers injected leptin-producing genes into obese mice that did not produce the protein. To deliver the genes, researchers used a molecular vehicle known as the adeno-associated virus, a harmless virus that already exists in the majority of the adult human population. The genes were engineered to be passengers inside the vehicle virus.

Once inside the mice, the genes integrated into their cells and acted like small factories, producing increased levels of leptin. The result was weight loss in less than three weeks. Normal, lean rats given the leptin genes maintained their body weight for three months, the duration of the experiment.

Because some obese people have a resistance to leptin, the research team also experimented with an alternative appetite-suppressing protein, CNTF.

"CNTF doesn't naturally secrete from a cell, but we wanted it to be secreted and get into the brain and signal to the cells that the person should stop eating," Zolotukhin said. "So we had to redesign CNTF and put a secretion signal that now drives it out of the cell and intocirculation."

The enhanced CNTF gene was inserted into the adeno-associated virus and administered to rats. After six weeks, researchers observed a decrease in body weight and food intake in the rats similar to that in the mice treated with the leptin gene. The CNTF rats have been under observation for six months and had no side effects.

UF researchers now are looking to evaluate other proteins that affect appetite control.

Kalra said human application of these drugs still is in the distant future. Clinical study of CNTF and leptin gene therapy in humans will not be approved until researchers can prove that these gene treatments are safe and without side effects.

----------------------------------------

Recent UF Health Science Center news releases are available at http://www.health.ufl.edu/hscc/index.html

The University of Florida Brain Institute -- http://www.ufbi.ufl.edu


Story Source:

The above story is based on materials provided by University Of Florida. Note: Materials may be edited for content and length.


Cite This Page:

University Of Florida. "University of Florida Researchers Explore Gene Therapy To Treat Obesity." ScienceDaily. ScienceDaily, 11 June 1999. <www.sciencedaily.com/releases/1999/06/990610115637.htm>.
University Of Florida. (1999, June 11). University of Florida Researchers Explore Gene Therapy To Treat Obesity. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/1999/06/990610115637.htm
University Of Florida. "University of Florida Researchers Explore Gene Therapy To Treat Obesity." ScienceDaily. www.sciencedaily.com/releases/1999/06/990610115637.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins